MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)
Clinical trial NCT00443703 · TERMINATED
Trial details
- NCT number
- NCT00443703
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2009-04-01
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.